The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Energy Restriction and Weight Loss on Very-Low-Fat Diets Reduce C-Reactive Protein Concentrations in Obese, Healthy Women
Abstract
Abstract —C-reactive protein (CRP) is an inflammatory-response protein that is a strong, independent predictor of cardiovascular mortality. CRP is positively associated with body mass index (BMI). In this study, we investigated the effects of dynamic weight loss on CRP in 83 healthy, obese women (mean BMI, 33.8±0.4 kg/m 2 ; range, 28.2 to 43.8 kg/m 2 ). Subjects were placed on very-low-fat, energy-restricted diets (5700 kJ, 15% fat) for 12 weeks. Weight, waist and hip circumferences, plasma lipids, glucose, and CRP were measured at baseline and after 12 weeks. CRP was positively associated with BMI ( r =0.281, P =0.01) and waist circumference ( r =0.278, P =0.01) but was not related to other atherosclerosis risk factors. BMI was significantly different between groups split above or below the median for CRP (34.8±0.6 kg/m 2 vs 33.0±0.5 kg/m 2 , P =0.02). After 12 weeks, weight loss was 7.9±0.3 kg. CRP was significantly decreased by 26% ( P <0.001), and a correlation was observed between weight loss and the change in CRP ( r =0.309, P =0.005). The variance in the change in CRP was partly explained by initial CRP (13.6%), energy intake (5.4%), and percentage weight loss (4.6%, P =0.001). This study confirms recent observations that BMI is associated with CRP, a marker for low-grade systemic inflammation. Furthermore, we observed that CRP was lowered in proportion to weight loss.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Strong associations between subsequent reductions in body weight, HbA1c, and visceral fat and reductions in inflammatory biomarkers were found in several of the trials included in our evaluation (7, 28, 35, 51, 52).”
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Elevated C-reactive protein levels in overweight and obese adults
Visser, M. (1999) · JAMA · doi:10.1001/jama.282.22.2131 · Cited by 2,494
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1
Mohamed‐Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., Klein, S., & Coppack, S. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4450 · Cited by 2,032
Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-499_7 · Cited by 1,591
Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein
Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F. M., & Braunwald, E. (1999) · Circulation · doi:10.1161/01.cir.100.3.230 · Cited by 1,471
Bastard, J., Jardel, C., Bruckert, É., Blondy, P., Capeau, J., Laville, M., Vidal, H., & Hainque, B. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6839 · Cited by 1,124
Flagged first, then by citations
Research works printed but not linked: 10
- 10.1161/atvb.19.8.1986 · DOI
- 10.1161/atvb.19.4.972 · DOI
- 1995, Int J Obes Relat Metab Disord, 1, 67
- 2000, J Clin Endocrinol Metab, 85, 3338
- 1997, J Clin Endocrinol Metab, 82, 4196
- 1996, Am J Epidemiol, 996, 537
- 10.1161/circ.98.8.731 · DOI
- 10.1161/circ.100.7.713 · DOI
- 1999, Int J Obes Relat Metab Disord, 9, 948
- 10.1161/circ.100.3.230 · DOI
Cited by
Sorted by citations
Items 301–329 of 329
Sundell, J., Laine, H. K., Nuutila, P., Luotolahti, M., & Knuuti, J. M. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803164
Valek, J. S., & Forsythe, C. E. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-302-8_25
Left ventricular hypertrophy and its detection in an African community
Maunganidze, F. (2014)
Examining the Relationship of Physical Activity with Inflammation and Cardiovascular Disease Risk
Gubler, C. (2007) · ProQuest Demo Repository
A biomarker of inflammation in cardiovascular disease
Feuerstein, G., Firestein, R., Libby, P., & Mann, D. L. (2003) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8047-3_2
Medidas Antropométricas e Proteína C Reativa como Indicadores de Doença Aterosclerótica
Trindade, M., da Silva, S., da Costa, C. L., & Martucci, R. B. (2009)
Prävention und Therapie der Adipositas Autoren
Hauner, H., Buchholz, G., Hamann, A., Husemann, B., Koletzko, B. V., Liebermeister, H., Wabitsch, M., Wirth, A. G., Wolfram, G., Scherbaum, W. A., et al. (2005)
Thompson, L. U., & Ward, W. E. (2007) · CRC Press eBooks · doi:10.1201/9781420043013-15
Role of Exercise and Weight Loss in Reducing Inflammation
You, T., & LaMonte, M. J. (2009) · Oxidative stress and disease · doi:10.1201/9781420091311.ch14
Insulin Resistance, Obesity, Body Fat Distribution, and Risk of Cardiovascular Disease
Shetty, G. K., & Mantzoros, C. S. (2006) · Fundamental and clinical cardiology · doi:10.3109/9781420018905.003
Dietary management of Polycystic ovary syndrome.
Moran, L. (2007) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
The effects of short-term low-carbohydrate and ketogenic interventions on cardiometabolic health
Myette‐Côté, É. (2019) · cIRcle (University of British Columbia) · doi:10.14288/1.0378478
CHAPTER 28 – Endocannabinoid Receptor Blockers
Despres, J. (2009) · Elsevier eBooks · doi:10.1016/b978-141605469-6.50032-9
고중성지방혈증 환자에서 Fenofibrate가 C-reactive protein 농도에 미치는 효과
이성호, 이경헌, 최여진, 이광호, 최수희, 이경은, 이광제, 김태호, 고홍숙, Jeong, K. C., et al. (2006) · The Korean Journal of Internal Medicine
Obesity and atherosclerosis: role of adipokines
Denisenko, A. D. (2010) · Medical academic journal · doi:10.17816/maj10445-49
Hyperglycemia as a component of metabolic syndrome and the main important factor of its progression
Kriachok, T. A., & Vavilova, L. L. (2014) · Bukovinian Medical Herald · doi:10.24061/2413-0737.xviii.1.69.2014.15
(2018) · Wiley eBooks · doi:10.1002/9781118829875.refs
Weight Loss and Metabolic Diseases
Pi-Sunyer, X. (2004) · CRC Press eBooks · doi:10.1201/9780203508756.ch10
Clifton, P. M. (2007) · CRC Press eBooks · doi:10.1201/9781420043013.sec3
Self-citationImmune Cells in Adipose Tissue: Key Players in Metabolic Disorders
Volat, F., & Bouloumié, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8069-3_11
(2005) · Wiley eBooks · doi:10.1002/9780470774663.refs
Шрамко, В. С., Stryukova, E. V., Polonskaya, Y. V., Stakhneva, E. M., Ragino, Y. I., & Kashtanova, E. V. (2022) · Russian Journal of Preventive Medicine · doi:10.17116/profmed20222507159
Camhi, S. M. (2008) · University Libraries (University of Maryland)
Bikman, B. T. (2005) · ScholarsArchive (Brigham Young University)
Srinivasan, B. T. (2011) · Leicester Research Archive (University of Leicester)
Rice, D. J. (2011) · D-Scholarship@Pitt (University of Pittsburgh)
Weight Loss and Metabolic Diseases
Pi-Sunyer, F. X. (2004) · CRC Press eBooks · doi:10.1201/9780203508756-20
Metadata
- Authors
- Heilbronn, L. K., Noakes, M., & Clifton, P. M.
- Affiliations
- Commonwealth Scientific and Industrial Research Organisation (AU)
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2001-06
- Volume
- 21
- Issue
- 6
- Pages
- 968-970
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2163805110
- Cited by
- 331
- References
- 18
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 3 · 2021: 7 · 2020: 4 · 2019: 7 · 2018: 4 · 2017: 8 · 2016: 7 · 2015: 11 · 2014: 11 · 2013: 12 · 2012: 17
- FWCI
- 19.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- C-reactive protein, very low-fat diet, caloric restriction, weight loss, obesity, body mass index, waist circumference, low-grade inflammation, cardiovascular risk
- MeSH terms
- Body Constitution, C-Reactive Protein, Energy Intake, Female, Humans, Middle Aged, Obesity, Weight Loss, Body Mass Index, Diet, Fat-Restricted
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
